CASP8 and glioblastoma: To further investigate the role of p62/SQSTM1 in the sensitization to TRAIL observed in GBM cells after PIM disabling, we performed co-immunoprecipitation assays to test whether p62/SQSTM1 interacts with caspase-8 upon TRAIL treatment as reported in other tumor cells36.